| |
Xconomy Exome Presents - New York Biotech
|
| With Steve Holtzman (CEO, Decibel Therapeutics), Jeremy Levin (CEO, Ovid Therapeutics), David Epstein (Partner, Flagship Pioneering), Jenna Foger (SVP Science & Tech, Alexandria Venture Investments). |
| Riverpark at Alexandria Center for Life Science, 450 E 29th St |
|
Jun 21 (Thu) , 2018 @ 06:00 PM
| |
$40 |
|
|
|
|
|
|
|
|
| |
/-73.97373199,40.73980713,13,0,0/550x200?access_token=pk.eyJ1IjoiZ2FyeXNndWlkZSIsImEiOiJjamtobmRiYmgwb3gwM3F1a2o2Mmd0YWw3In0.DinA62CR3-OKtf3axa5O7Q)
|
| |
| DETAILS |
|
They grew up in Brooklyn. Queens. The Bronx. Staten Island. They became top scientists, & eventually life sciences entrepreneurs. And like many others before them, they rose to biopharma prominence only after leaving New York.
They're the New York expats, & to many in the New York life sciences scene, they're seen as key to the area's ambitions to nurture & grow its biotech sector-if they'll only come back & lead companies in the Big Apple.
For one evening, Xconomy is going to make that happen. We are bringing together a few biopharma leaders who are ex-New Yorkers to lead a unique, candid discussion with the local biotech community. Why did they leave New York? What do they make of their former home from afar? And what would entice them, & others like them, to take a shot on a New York company?
|
|
|
|
|
|
|
|
